Related Experiment Videos
Evolution of a neonatal gentamicin dosing protocol in a small community hospital
M P Rivey1, G L North, D A Harper
1Community Medical Center, Missoula, Montana.
Abstract:
The effects of conventional dosage of gentamicin of 2.5 mg/kg given every 12 hours was retrospectively investigated in a small community hospital. Consistent with previous results in large hospitals, the conventional dosage of gentamicin commonly resulted in serum concentrations associated with toxicosis. Results were compared with those obtained prospectively according to a gentamicin dosing protocol that used a formula based on gestational age. The gestational age regimen provided similar peak and significantly lower trough serum concentrations; statistical analysis indicated no demographic differences in the compared groups. Very few neonates who received gentamicin according the gestational age formula were exposed to gentamicin serum concentrations associated with an increased risk of toxicosis. An absence of any significant differences in mean peak and trough serum concentrations in subgroups of neonates treated according to the gestational age formula suggested that use of the gentamicin dosing protocol was appropriate for all neonates. The dose of 3.5 mg/kg used in the gestational age formula was predicted to have resulted in initial gentamicin peak serum concentrations > 5 micrograms/ml in nearly 90% of neonates. The experience obtained with the gestational age formula allowed revision of the gentamicin dosing protocol to provide for more cost-responsible serum concentration monitoring.
Insights
A new gentamicin dosing protocol based on gestational age significantly lowers toxic drug levels in neonates. This approach ensures safer gentamicin therapy for newborns, reducing the risk of adverse effects and improving monitoring.
Area of Science:
- Neonatal pharmacology
- Pediatric pharmacokinetics
- Antibiotic dosing strategies
Background:
- Conventional gentamicin dosing (2.5 mg/kg every 12 hours) often leads to toxic serum concentrations in neonates, mirroring findings in larger hospitals.
- Neonatal gentamicin therapy requires careful dosing to balance efficacy and minimize nephrotoxicity and ototoxicity.
Purpose of the Study:
- To evaluate a gentamicin dosing protocol based on gestational age compared to conventional dosing in neonates.
- To assess the safety and efficacy of adjusted gentamicin serum concentrations in a neonatal population.
Main Methods:
- Retrospective analysis of conventional gentamicin dosing.
- Prospective evaluation of a gentamicin dosing protocol utilizing a formula based on gestational age.
- Comparison of peak and trough serum gentamicin concentrations between the two dosing strategies.
Main Results:
- The gestational age-based regimen achieved similar peak but significantly lower trough serum concentrations compared to conventional dosing.
- Very few neonates on the gestational age protocol experienced gentamicin levels associated with toxicosis risk.
- No significant demographic differences were observed between the groups, supporting the protocol's general applicability.
Conclusions:
- Gentamicin dosing tailored to gestational age is a safe and effective strategy for neonates.
- This protocol optimizes gentamicin therapy, reducing the risk of toxicity and allowing for more cost-effective serum concentration monitoring.
- The revised protocol ensures appropriate gentamicin peak concentrations while minimizing trough levels associated with toxicity.